Diabetes Breakthroughs Happen with 3D InSight™
Meet the InSphero team at the American Diabetes Association 2018 meeting to learn how you can take full advantage of our 3D InSight™ Diabetes Discovery Platform.
Robust Islet Models Expert Assay Services
Uniform 3D InSight™ Microtissues
for reproducible results
Reliable Assessment of β-cell Function
Talk to our team at ADA to learn about our new partnership with ALPCO and our comprehensive β-cell function application suite that includes everything you need to quantify insulin secretion from 3D InSight™ Islet Microtissues.
- Use a robust and standardized primary islet model in high-throughput and longitudinal studies of β-cell function, regeneration and preservation
- Achieve robust and accurate quantification of insulin secretion from 3D InSight™ Islet Microtissues with the high sensitivity and broad dynamic range of ALPCO STELLUX® ELISAs
- Save time and ensure reliable, reproducible results by ordering media, buffers, and endpoint assays certified for use with 3D InSight™ Islet Microtissues
In-Booth Poster Presentations
The following posters will be on display at InSphero Booth 1567, during exhibition hours, June 23 – 25.
Contributing Authors: Aparna Neelakandhan1, Adelinn Biernath1, Felix Forschler1, Joan Mir, Burcak Yesildag1; 1 InSphero AG, Schlieren, Switzerland
Insulin Release Dynamics
Contributing Authors: Burcak Yesildag1, Patrick M. Misun2, Felix Forschler2, Aparna Neelakandhan1, Adelinn Biernath1, Andreas Hierlemann2, Olivier Frey1; 1 InSphero AG, Schlieren, Switzerland; 2 ETH Zürich, Dept. of Biosystems Science and Engineering, Bio Engineering Laboratory, Basel, Switzerland
Contributing Authors: Burcak Yesildag1, Eva-Marie Andersson2, Aparna Neelakandhan1, Adelinn Biernath1, Laurent Knerr2, Henrik Gradén2, Carina Ämmälä2; 1InSphero AG, Schlieren, Switzerland, 2AstraZeneca, Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit – Mölndal, Sweden
Pancreatic Islets on a Chip
Contributing Authors: Fabrizio Hürlimann¹, Christian Lohasz², Burçak Yesildag¹, David Fluri¹, Kasper Renggli², Andreas Hierlemann², Olivier Frey¹; ¹InSphero AG, Schlieren, Switzerland; ²ETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland